Ronald P Taylor

This inventor holds 15 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: University of Virginia Patent Foundation, Genmab Holding B.v., The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 1995-2025.

USPTO Granted Patents = 15 (Patent Applications = 5)

% Patents Active = 66.7

EPO Patents = 1

Average Co-Inventor Count = 5.8

ph-index = 6

Forward Citations = 317(Granted Patents)

Location History:

Charlottesville, VA (US) (1995 - 2010)
Keswick, VA (US) (2018 - 2022)

Company Filing History:

11 out of 1,040

University of Virginia Patent Foundation

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

4. 2 out of 2,651

University of Pennsylvania

patents

where one patent can have more than one assignee

Years Active: 1995-2025

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12275797 - Anti-CD37 antibodies and anti-CD20 antibodies, compositions and methods of use thereof (2025-04-14),

2. 11512137 - Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof (2022-11-29),

3. 11396553 - Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof (2022-07-26),

4. 11384139 - Antibody targeting cell surface deposited complement protein C3d and use thereof (2022-07-12),

5. 11034772 - Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof (2021-06-15),

6. 10035848 - Antibody targeting cell surface deposited complement protein C3d and use thereof (2018-07-31),

7. 7858087 - Enhancing the efficacy of immunotherapies by supplementing with complement (2010-12-28),

8. 7837997 - Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots (2010-11-23),

9. 7378094 - Therapeutic uses of complement receptor 2 (2008-05-27),

10. 7255858 - Enhancing the efficacy of immunotherapies by supplementing with complement (2007-08-14),

11. 7172760 - Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots (2007-02-06),

12. 6572856 - Methods for the prevention and treatment of cancer using anti-C3b(i) antibodies (2003-06-03),

13. 5879679 - Antigen-based heteropolymers and method for treating autoimmune diseases (1999-03-09),

14. 5487890 - Mammalian primate erythrocyte bound heteropolymerized monoclonal (1996-01-30),

15. 5470570 - Mammalian primate erythrocyte bound heteropolymerized monoclonal (1995-11-28),

Title: Inventor Ronald P Taylor - Revolutionizing Technology

Introduction: Ronald P Taylor, a distinguished inventor based in Charlottesville, VA, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Ronald P Taylor holds several patents in cutting-edge technologies related to artificial intelligence, renewable energy, and biotechnology, showcasing his versatility and forward-thinking approach.

Career Highlights: With over two decades of experience in the industry, Ronald P Taylor has led numerous research projects that have resulted in game-changing inventions, earning him recognition as a pioneer in his field.

Collaborations: Throughout his career, Ronald P Taylor has collaborated with leading research institutions, universities, and tech companies to further develop and implement his innovative ideas, fostering a culture of creativity and progress.

Conclusion: In conclusion, Ronald P Taylor's passion for innovation and his relentless pursuit of excellence have solidified his position as a trailblazer in the world of technology, with his inventions poised to shape the future of various industries.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]